Diagnostic accuracy of IgA anti-tissue transglutaminase antibody testing in celiac disease [PDF]
Contemporary guidelines for the first-line diagnosis of celiac disease recommend determination of IgA anti-tissue transglutaminase antibodies or IgA antiendomysial antibodies, as well as total serum IgA antibodies.
Eremić Nevena +2 more
doaj +3 more sources
Anti-tissue transglutaminase antibodies in inflammatory and degenerative arthropathies [PDF]
Recent studies identified tissue transglutaminase (tTG) as the antigen eliciting antiendomysial antibodies (EMA) in celiac disease (CD). Anti-tTG antibodies have therefore been proposed as a serological test for CD. Nevertheless, IgA anti-tTG but not EMA
A. Spadaro +6 more
doaj +8 more sources
LFRET, a novel rapid assay for anti-tissue transglutaminase antibody detection. [PDF]
The diagnosis of celiac disease (CD) is currently based on serology and intestinal biopsy, with detection of anti-tissue transglutaminase (tTG) IgA antibodies recommended as the first-line test.
Juuso Rusanen +8 more
doaj +10 more sources
Anti-tissue transglutaminase antibodies not related to gluten intake
Introduction: Anti-tissue transglutaminase antibodies (tTG) have high specificity for coeliac disease (CD). However, positive anti-tTG antibodies have been described in non-coeliac patients.
Mónica Garcia-Peris +5 more
doaj +4 more sources
Anti-tissue transglutaminase antibodies and their role in the investigation of coeliac disease [PDF]
Coeliac disease (CD), caused by an inappropriate T-cell-mediated immune response to the ingestion of cereal proteins in genetically susceptible individuals, is a common disorder with a prevalence of about 1% in Caucasian populations. It has a strong association with other autoimmune disorders, particularly type 1 diabetes and autoimmune thyroid disease.
P G, Hill, S A, McMillan
openaire +2 more sources
Granular deposits of IgA represent the specific cutaneous marker of dermatitis herpetiformis. The prevalence of IgA deposits in the skin of patients with coeliac disease without dermatitis herpetiformis remains unknown.
Emiliano Antiga +11 more
doaj +1 more source
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ [PDF]
Background and aims: Coeliac disease (CD) is a multifactorial disorder which has an autoimmune component characterised by the occurrence of disease specific autoreactive antibodies against the enzyme tissue transglutaminase (tTG).
ESPOSITO, Carla +10 more
openaire +9 more sources
Anti-Tissue Transglutaminase Antibodies in Arthritic Patients: A Disease-specific Finding? [PDF]
Tissue transglutaminase (tTG), widely distributed in human organs, is a multifunctional enzyme involved in the cross-linking of extracellular matrix proteins, fibrogenesis, and wound healing (1). Recently, tTG has been proposed as the autoantigen of anti-endomysial antibodies (EMAs) (2), a serologic marker of celiac disease (CD) (3).
PICARELLI, Antonio +7 more
openaire +2 more sources
Anti‐tissue transglutaminase antibodies in the follow‐up of adult coeliac disease [PDF]
SummaryBackground The detection of auto antibodies directed against tissue transglutaminase (anti‐tTG antibodies) has a well‐established role in the diagnosis of coeliac disease, but the value of these antibodies in long‐term follow‐up is controversial.Aims To determine if serial anti‐tTG antibody measurements could confirm adherence to a gluten‐free
C. R. Dipper +8 more
openaire +3 more sources
Role of age in dynamics of autoantibodies in pediatric Celiac disease
Background Celiac disease (CD) is characterized by elevated serum titers of autoantibodies IgA anti-tissue transglutaminase 2 (TGA-IgA) and IgA anti-endomysial (EMA), with small bowel mucosa atrophy.
Chiara Maria Trovato +5 more
doaj +1 more source

